Bradley & Co Private Wealth Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-7
Closed -$710 217
2025
Q4
$710 Buy
+7
New +$562 ﹤0.01% 203
2023
Q4
Sell
-318
Closed -$21.7K 201
2023
Q3
$21.7K Hold
318
0.02% 92
2023
Q2
$29.9K Sell
318
-14
-4% -$1.09K 0.03% 77
2023
Q1
$22.5K Hold
332
0.02% 91
2022
Q4
$16.4K Hold
332
0.02% 105
2022
Q3
$10K Hold
332
0.01% 125
2022
Q2
$14K Hold
332
0.02% 127
2022
Q1
$23K Hold
332
0.02% 108
2021
Q4
$26K Hold
332
0.02% 111
2021
Q3
$31K Hold
332
0.03% 108
2021
Q2
$42K Hold
332
0.04% 103
2021
Q1
$44K Buy
+332
New +$45.4K 0.04% 100

Other funds holding EXAS

Bradley & Co Private Wealth Management's EXAS Position: Q1 2026 in Review

Bradley & Co Private Wealth Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 7 shares — an estimated $710 sold.

Bradley & Co Private Wealth Management first reported a position in EXAS in Q1 2021 and held it in 12 quarters. The position peaked at $44K in Q1 2021. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Bradley & Co Private Wealth Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Bradley & Co Private Wealth Management sold 7 Exact Sciences shares in Q1 2026, an estimated $710.
  • Bradley & Co Private Wealth Management first reported a position in Exact Sciences in Q1 2021 and held it in 12 quarters.
  • Bradley & Co Private Wealth Management's Exact Sciences position peaked at $44K in Q1 2021.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Bradley & Co Private Wealth Management's 13F filing for Q1 2026, filed 13 May 2026.